Biomedical applications of functional peptides in nano-systems
Source abstract
Abstract
Abstract During the past decades, functionalized nano-systems were believed in holding the bright future of the nanomaterials in biomedical applications. Due to their excellent biocompatibility, biodegradation capability, and biological activity, functional peptides have been vastly used solitary or employed as functional components in nano-systems for disease treatments. This review focuses on the recent advances on the use of functional peptides as a toolbox to construct various delivery nano-systems for tumor treatments. Arising from the special function contributed to the nano-systems, the functional peptides are mainly divided into three groups, cell-targeting peptides (CTPs), cell-penetrating peptides (CPPs), and environment-sensitive peptides. Within each group, their usage in both organic and inorganic systems is discussed. In particular, strategies used to generate promising therapeutic nano-systems for efficient tumor treatment are also highlighted.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Supramolecular Self-Assembly in Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Combinatorial peptide libraries: mining for cell-binding peptides10.1021/cr400166n ↗
2. Virus-derived peptides for clinical applications10.1021/acs.chemrev.7b00100 ↗
3. Bioactive peptides grafted silicone dressings: a simple and specific method10.1016/j.mtchem.2017.02.007 ↗
4. Photochemical tuning of materials: a click chemistry perspective10.1016/j.mtchem.2018.03.002 ↗
5. Recent advances on electrospun scaffolds as matrices for tissue-engineered heart valves10.1016/j.mtchem.2017.05.001 ↗
6. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery10.1038/nrd4333 ↗
7. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides10.1016/j.jconrel.2017.02.006 ↗
8. Peptides for cell-selective drug delivery10.1016/j.tips.2012.02.002 ↗
9. Self-assembled peptide–lanthanide nanoclusters for safe tumor therapy: overcoming and utilizing biological barriers to peptide drug delivery10.1021/acsnano.8b00081 ↗
10. Targeted Co-delivery of PTX and TR3 siRNA by PTP peptide modified dendrimer for the treatment of pancreatic cancer10.1002/smll.201602697 ↗
11. Stimuli-responsive “Cluster Bomb” for programmed tumor therapy10.1021/acsnano.7b03088 ↗
12. Cell-penetrating peptides: classes, origin, and current landscape10.1016/j.drudis.2012.03.002 ↗
13. Cell-penetrating peptides: breaking through to the other side10.1016/j.molmed.2012.04.012 ↗
14. An innovative pre-targeting strategy for tumor cell specific imaging and therapy10.1039/C5NR03862F ↗
15. Synthetic therapeutic peptides: science and market10.1016/j.drudis.2009.10.009 ↗
16. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
17. Application of nanomaterials in cancer immunotherapy10.1016/j.mtchem.2018.01.001 ↗
18. Multifunctional dendritic polymers in nanomedicine: opportunities and challenges10.1039/C1CS15242D ↗
19. Strategies in the design of nanoparticles for therapeutic applications10.1038/nrd2591 ↗
20. Specialization of tumour vasculature10.1038/nrc724 ↗
21. Peptide functionalized nanoparticles for nonviral gene delivery10.1039/C2SM26633D ↗
22. Targeting of drugs and nanoparticles to tumors10.1083/jcb.200910104 ↗
23. High-affinity RGD-knottin peptide as a new tool for rapid evaluation of the binding strength of unlabeled RGD-peptides to αvβ3, αvβ5, and α5β1 integrin receptors10.1021/acs.analchem.7b00554 ↗
24. RGD and other recognition sequences for integrins10.1146/annurev.cellbio.12.1.697 ↗
25. Integrin ligands at a glance10.1242/jcs.03098 ↗
26. Peptide REDV-modified polysaccharide hydrogel with endothelial cell selectivity for the promotion of angiogenesis10.1002/jbm.a.35306 ↗
27. Biopolymer implants enhance the efficacy of adoptive T-cell therapy10.1038/nbt.3104 ↗
28. Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin αIIbβ310.1083/jcb.200801146 ↗
29. Dual-targeted peptide-conjugated multifunctional fluorescent probe with AIEgen for efficient nucleus-specific imaging and long-term tracing of cancer cells10.1039/C7SC00402H ↗
30. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin10.1016/j.biomaterials.2010.09.014 ↗
31. Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin-inducer peptides10.1158/1535-7163.MCT-09-0228 ↗
32. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers10.1038/nmat2992 ↗
33. Novel peptide-doxorubucin conjugates for targeting breast cancer cells including the multidrug resistant cells10.1021/jm400647r ↗
34. Lung cancer-targeting peptides with multi-subtype indication for combinational drug delivery and molecular imaging10.7150/thno.17573 ↗
35. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with loperamide and rhodamine-12310.1016/j.jconrel.2007.05.022 ↗
36. A synthetic peptide containing loop 4 of nerve growth factor for targeted gene delivery10.1002/jgm.610 ↗
37. Design of nanostructures based on aromatic peptide amphiphiles10.1039/C4CS00247D ↗
38. 25th anniversary article: supramolecular materials for regenerative medicine10.1002/adma.201304606 ↗
39. Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response10.1016/j.biomaterials.2012.06.003 ↗
40. Functional supramolecular polymers10.1126/science.1205962 ↗
41. Supramolecular biomaterials10.1038/nmat4474 ↗
42. Supramolecular biofunctional materials10.1016/j.biomaterials.2017.03.014 ↗
43. Peptide-based molecular hydrogels as supramolecular protein mimics10.1002/chem.201602624 ↗
44. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model10.1126/science.279.5349.377 ↗
45. Tumor angiogenesis: molecular pathways and therapeutic targets10.1038/nm.2537 ↗
46. Integrin targeted delivery of chemotherapeutics10.7150/thno/v01p0189 ↗
47. Environmentally responsive peptides as anticancer drug carriers10.1016/j.addr.2009.07.002 ↗
48. Recent advances in self-assembled peptides: implications for targeted drug delivery and vaccine engineering10.1016/j.addr.2016.06.013 ↗
49. Self-delivery of a peptide-based prodrug for tumor-targeting therapy10.1007/s12274-015-0945-1 ↗
50. Adjustable nanofibers self-assembled from an irregular conformational peptide amphiphile10.1039/C4PY01237B ↗
51. Self-assembled tat nanofibers as effective drug carrier and transporter10.1021/nn401667z ↗
52. Self-assembling small molecules for the detection of important analytes10.1039/C4CS00161C ↗
53. Construction of surfactant-like tetra-tail amphiphilic peptide with RGD ligand for encapsulation of porphyrin for photodynamic therapy10.1016/j.biomaterials.2010.10.047 ↗
54. Supramolecular “Trojan horse” for nuclear delivery of dual anticancer drugs10.1021/jacs.6b12322 ↗
55. Targeted chemo-photodynamic combination platform based on the dox prodrug nanoparticles for enhanced cancer therapy10.1021/acsami.7b00927 ↗
56. Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery10.2147/IJN.S55875 ↗
57. Bifunctional elastin-like polypeptide nanoparticles bind rapamycin and integrins and suppress tumor growth in vivo10.1021/acs.bioconjchem.7b00469 ↗
58. Smart and hyper-fast responsive polyprodrug nanoplatform for targeted cancer therapy10.1016/j.biomaterials.2015.10.056 ↗
59. ROS-responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy10.1002/adma.201700141 ↗
60. The relationship between the cyclic-RGDfK ligand and αvβ3 integrin receptor10.1016/j.biomaterials.2013.04.065 ↗
61. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides10.1039/C4DT02710H ↗
62. Cyclo(RGD)-decorated reduction-responsive nanogels mediate targeted chemotherapy of integrin overexpressing human glioblastoma in vivo
63. Targeted soft biodegradable glycine/PEG/RGD-modified poly(methacrylic acid) nanobubbles as intelligent theranostic vehicles for drug delivery10.1021/acsami.7b11392 ↗
64. Transformable nanomaterials as an artificial extracellular matrix for inhibiting tumor invasion and metastasis10.1021/acsnano.7b00781 ↗
65. NGR tumor-homing peptides: structural requirements for effective APN (CD13) targeting10.1021/acs.bioconjchem.6b00136 ↗
66. NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel10.1016/j.colsurfb.2017.09.052 ↗
67. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy10.18632/oncotarget.9889 ↗
68. Glycine N-methylation in NGR-tagged nanocarriers prevents isoaspartate formation and integrin binding without impairing cd13 recognition and tumor homing10.1002/adfm.201701245 ↗
69. Mri-visible micellar nanomedicine for targeted drug delivery to lung cancer cells10.1021/mp9001393 ↗
70. Active targeting schemes for nanoparticle systems in cancer therapeutics10.1016/j.addr.2008.08.005 ↗
71. Drug delivery and release systems for targeted tumor therapy10.1002/psc.2753 ↗
72. Mesoporous silica nanoparticles for drug delivery and biosensing applications10.1002/adfm.200601191 ↗
73. Nanomedicine: veni, vidi, vici and then... vanished10.1038/nmat2413 ↗
74. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers10.1016/j.addr.2008.03.012 ↗
75. Mesoporous silica nanoparticles in biomedical applications10.1039/c1cs15246g ↗
76. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics-the trio of imaging, targeting and therapy10.1039/c0jm00645a ↗
77. Ligand conformation dictates membrane and endosomal trafficking of Arginine-Glycine-Aspartate (RGD)-functionalized mesoporous silica nanoparticles10.1002/chem.201200023 ↗
78. A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles10.1039/C4TB01533A ↗
79. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers10.1021/nn204102q ↗
80. Plasmonic nanoparticles with quantitatively controlled bioconjugation for photoacoustic imaging of live cancer cells
81. Targeted tumor SPECT/CT dual mode imaging using multifunctional RGD-modified low generation dendrimer-entrapped gold nanoparticles10.1039/C7BM00826K ↗
82. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles10.1016/j.jconrel.2016.08.041 ↗
83. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-12510.1002/smll.201100927 ↗
84. Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy10.7150/thno.6630 ↗
85. RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy10.1021/mp9001415 ↗
86. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands10.1021/nn102055s ↗
87. Targeting cancer cell integrins using gold nanorods in photothermal therapy inhibits migration through affecting cytoskeletal proteins10.1073/pnas.1703151114 ↗
88. Homing peptide-conjugated gold nanorods: the effect of amino acid sequence display on nanorod uptake and cellular proliferation10.1021/bc500174b ↗
89. Upconversion and anti-stokes processes with f and d ions in solids10.1021/cr020357g ↗
90. Recent progress in rare earth micro/nanocrystals: soft chemical synthesis, luminescent properties, and biomedical applications10.1021/cr4001594 ↗
91. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics10.1021/cr400425h ↗
92. Immunolabeling and NIR-excited fluorescent imaging of Hela cells by using NaYF4:Yb,Er upconversion nanoparticles10.1021/nn900491j ↗
93. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors10.1021/ac901960d ↗
94. Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under near-infrared irradiation10.1016/j.biomaterials.2010.07.099 ↗
95. A nanoscale graphene oxide-peptide biosensor for real-time specific biomarker detection on the cell surface10.1039/c2cc31974h ↗
96. In vitro derby imaging of cancer biomarkers using quantum dots10.1002/smll.200801580 ↗
97. Photocatalyzing CO2 to CO for enhanced cancer therapy10.1002/adma.201703822 ↗
98. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses10.1039/C1CS15258K ↗
99. Cell-penetrating and cell-targeting peptides in drug delivery10.1016/j.bbcan.2008.03.001 ↗
100. A holistic approach to targeting disease with polymeric nanoparticles10.1038/nrd4503 ↗